HomeToday’s HighlightsThe Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. The Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. Today’s Highlights April 8, 2019 The Amgen/Novartis Story In May 2018 Amgen (AMGN) & Novartis (This content is for paid subscribers. Please click here to subscribe or here to log in. Today’s Highlights Alder BioPharmaceuticals (ALDR), Amgen (AMGN), Novartis (NVS) April 8, 2019 Tweet Pin It Other Articles Intellia Therapeutics and Immunovant Inc Positive Press Releases February 7, 2026 0 Sanofi’s Venglustat Met All Primary Endpoints in a Phase 3 Study of Type 3 Gaucher Disease February 2, 2026 0 Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN January 27, 2026 0 BioCryst Pharmaceuticals Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema January 26, 2026 0